BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Anavex Life Sciences Corp. (NASDAQ:AVXL)

1 post

Biotech NewsAnavex (AVXL) Gains as $120M Cash Fuels Next Alzheimer’s & Schizophrenia Trials

  • BioTech Health X
  • October 13, 2025
Anavex Life Sciences Corp. (NASDAQ:AVXL) is a cutting-edge clinical-stage biopharmaceutical company focused on discovering and developing novel therapies…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
  • AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
  • Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
  • Molina Healthcare (MOH) Crashes 39% in a Year
  • Tenax Therapeutics (TENX) Fully Funded Through 2027 With $105.5M Cash
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • October 14, 2025
    Tonix Pharmaceuticals (TNXP) Plunges 20% After FDA Win
    • October 14, 2025
    AstraZeneca (AZN) Targets $80 Billion Revenue by 2030
    • October 14, 2025
    Akero Therapeutics (AKRO) Soars 16.52% After Liver Drug Breakthrough Shocks Wall Street
    • October 14, 2025
    Molina Healthcare (MOH) Crashes 39% in a Year
    • October 13, 2025
    Tenax Therapeutics (TENX) Fully Funded Through 2027 With $105.5M Cash
Recent Posts
  • Inside Galectin (GALT)’s $18 Billion Shot at Reversing Liver Cirrhosis
    • October 13, 2025
  • Tvardi Therapeutics (TVRD) Could Be 2025’s Most Democratic Biotech Stock
    • October 13, 2025
  • Aldeyra Therapeutics (ALDX) Falls Below $5.40 as FDA Decision Looms
    • October 12, 2025
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (1)
  • Biotech News (471)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top